TY - JOUR AU - Martín, Alejandro AU - Conde, Eulogio AU - Arnan, Montserrat AU - Canales, Miguel A AU - Deben, Guillermo AU - Sancho, Juan M AU - Andreu, Rafael AU - Salar, Antonio AU - García-Sanchez, Pedro AU - Vázquez, Lourdes AU - Nistal, Sara AU - Requena, María-José AU - Donato, Eva M AU - González, José A AU - León, Angel AU - Ruiz, Concepción AU - Grande, Carlos AU - González-Barca, Eva AU - Caballero, María-Dolores PY - 2008 DO - 10.3324/haematol.13440 SN - 0390-6078 UR - http://hdl.handle.net/10668/1286 T2 - Haematologica AB - BACKGROUNDThe role of re-treatment with rituximab in aggressive B-cell lymphomas still needs to be defined. This study evaluated the influence of prior exposure to rituximab on response rates and survival in patients with diffuse large B-cell lymphoma... LA - en PB - Ferrata Storti Foundation KW - R-ESHAP KW - Diffuse large B-Cell lymphoma KW - Rituximab KW - Salvage therapy KW - Protocolos de quimioterapia antineoplásica combinada KW - Tratamiento de última línea KW - Linfoma de células B grandes difuso KW - Medical Subject Headings::Named Groups::Persons::Age Groups::Adult KW - Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Aged KW - Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal KW - Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal::Antibodies, Monoclonal, Murine-Derived KW - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Clinical Protocols::Antineoplastic Protocols::Antineoplastic Combined Chemotherapy Protocols KW - Medical Subject Headings::Chemicals and Drugs::Inorganic Chemicals::Chlorine Compounds::Cisplatin KW - Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Pyrimidines::Pyrimidine Nucleosides::Cytidine::Cytarabine KW - Medical Subject Headings::Chemicals and Drugs::Polycyclic Compounds::Steroids::Steroids, Fluorinated::Dexamethasone KW - Medical Subject Headings::Chemicals and Drugs::Carbohydrates::Glycosides::Glucosides::Etoposide KW - Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans KW - Medical Subject Headings::Diseases::Immune System Diseases::Immunoproliferative Disorders::Lymphoproliferative Disorders::Lymphoma::Lymphoma, Non-Hodgkin::Lymphoma, B-Cell::Lymphoma, Large B-Cell, Diffuse KW - Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Middle Aged KW - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies::Retrospective Studies KW - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Combined Modality Therapy::Salvage Therapy KW - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Treatment Outcome KW - Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Young Adult KW - Medical Subject Headings::Named Groups::Persons::Age Groups::Adolescent TI - R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study. TY - research article ER -